The researchers found that a biomarker in the blood called neurofilament light chain (NfL) increased after menopause. This ...

Immunic Therapeutics says it's "on track" in its MS clinical trials of vidofludimus calcium, with CALLIPER top-line data ...

When he was 25, he learned that he had multiple sclerosis. He coped with the disease throughout a long career at several ...

Columnist Ben Hofmeister explains a handy acronym that's helped him and can help you motivate yourself with MS.

UCSF study calls attention to the potential for estrogen therapy in slowing the course of the disease.A new study by UC San Francisco has found that ...

Contineum Therapeutics has concluded the targeted enrolment of 168 subjects in its Phase II trial of M1 receptor antagonist ...

Corvette ZR1 with the ZTK Performance Package and $25,000 cash by supporting MS Solutions and their work for MS patients.

Data from a systematic review of 30 real-world studies show comparable discontinuation rates of ocrelizumab to those in ...